ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO935

Does Dark Chocolate Intake Influence Magnesium Status in Hemodialysis Patients?

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1500 Health Maintenance, Nutrition, and Metabolism

Authors

  • Mafra, Denise, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  • Kemp, Julie Ann, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Fanton, Susane, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Baptista, Beatriz Germer, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil
  • Ribeiro, Marcia Maria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  • Ribeiro-Alves, Marcelo, Fundacao Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
  • Cardozo, Ludmila Fmf, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil

Group or Team Name

  • Renal Nutrition - UFF.
Background

Magnesium (Mg2+) is a fundamental mineral that maintains cell function. Magnesium deficiency can be observed in patients with CKD and is associated with increased inflammation, disease progression, and mortality. Studies have shown that patients with high Mg2+ serum levels have shown better survival. Dark chocolate is an excellent source of magnesium and polyphenols. Thus, the study aimed to evaluate the effects of 70% cocoa chocolate on magnesium plasma levels in patients with CKD on hemodialysis (HD).

Methods

These are secondary analyses from a previous controlled pilot study that included 59 CKD patients undergoing HD. Patients were allocated into two groups; the chocolate group received 40 grams of 70% cocoa chocolate during HD sessions (3 times a week) for two months. The control group did not receive any intervention. Routine biochemical parameters, including potassium, phosphorus and Mg2+, were evaluated by a colourimetric test using a commercial kit (Bioclin®).

Results

Thirty-five patients in the chocolate group (17 women, 53.4 ± 12.9 years) and 11 in the control group (4 women, 46.7 ± 10.9 years) completed the study. The median of Mg2+ serum levels was 2.4 (0.4) mg/dL, with no significant differences between the groups. After two months of supplementation, there was no change in potassium and phosphorus plasma levels, but the Mg2+ serum levels were significantly increased in the chocolate group (Figure 1).

Conclusion

Dark chocolate intake increased the Mg2+ serum levels in patients with CKD on HD. Therefore, dark chocolate might be a promising nutritional strategy to improve Mg2+ levels in patients with CKD on HD. The offered dose was safe, not altering plasma phosphorus and potassium levels.

Figure 1. Comparison of plasma magnesium levels before and after two months in the control and chocolate groups.

Funding

  • Government Support – Non-U.S.